COMMUNIQUÉS West-GlobeNewswire

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting

28/03/2024 - 14:23

Presentation will address the Company’s clinical data in Parkinson’s disease CAPE CANAVERAL, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new [...]

Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update

28/03/2024 - 14:15

Advanced OTX-2002 in MYCHELANGELO™ I trial; initial cohorts demonstrated encouraging disease control rate in late-stage HCC patients Established a research collaboration with Novo Nordisk to develop an epigenomic [...]

Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc

28/03/2024 - 14:03

Los Angeles, CA, March 28, 2024 (GLOBE NEWSWIRE) -- Endonovo (OTC PINK: ENDV) and its subsidiary, SofPulse, Inc., today announced they have finalized and completed the Asset Purchase Agreement (APA), originally signed [...]

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

28/03/2024 - 14:00

Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the fourth quarter of 2024 MB [...]

GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference

28/03/2024 - 14:00

Live webcast on Wednesday, April 3 rd at 10:10 AM ET LA JOLLA, CA, March 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of [...]

Get Ready to Elevate Your Chill Game with Evn's New Hybrid Gummies!

28/03/2024 - 14:00

NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Roll out the green carpet and get your taste buds ready for a delightful new twist in the world of hemp-derived delights—Evn's fresh-off-the-vine Hybrid Gummies are here! The [...]

JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet

28/03/2024 - 14:00

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the publication of results from the ALIGN [...]

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

28/03/2024 - 14:00

LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year [...]

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer

28/03/2024 - 13:30

Medical oncologist brings over 25 years of industry experience to lead Clinical Development Strategy BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company [...]

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

28/03/2024 - 13:30

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the [...]

CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors

28/03/2024 - 13:30

Funding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital $50 million financing upfront with up to an additional $99.4 million tied to exercise of [...]

Assure Holdings Closes Sale of Certain Assets to MPOWERHealth

28/03/2024 - 13:30

DENVER, March 28, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it [...]

Dyadic Announces Change in Board and Management Leadership Roles

28/03/2024 - 13:30

JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]

Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results

28/03/2024 - 13:30

First Patient Enrolled in Phase 3 LEVEL Trial Evaluating TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction (PH-HFpEF) Expansion of U.S. [...]

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

28/03/2024 - 13:30

Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group The data supports the Company’s strategy to offer military and civilian physicians [...]

SweetWater Brewing Launches Hammer Red Amber Ale to Support Georgia Aquarium

28/03/2024 - 13:30

The Limited-Release Seasonal Is Part of SweetWater’s On-going Partnership with Georgia Aquarium ATLANTA, March 28, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest [...]

Psychemedics Corporation Reports 2023 Financial Results

28/03/2024 - 13:20

DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, announced today financial results for the year ended December 31, 2023 [...]

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

28/03/2024 - 13:19

Collaborators at the University of Michigan will present new Data on InFoods ® IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: [...]

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

28/03/2024 - 13:15

As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN ® Nasal Spray and build on its longstanding efforts with [...]